The Biden administration announced Thursday that drug companies receiving research funding from HHS’ emergency response arm, the Administration for Strategic Preparedness and Response, will have to commit to a “fair price” – not more than they charge in other countries. Host Chelsea Cirruzzo talks with POLITICO health care reporter Robert King about the Biden administration's efforts to curb high prescription drug prices. Learn more about your ad choices. Visit megaphone.fm/adchoices
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from POLITICO's Pulse Check
The two big ways AI is changing health care
For HHS, AI is an inside job
A look back at abortion policy in 2023 and a look forward to 2024
Fentanyl’s fatal year in review
Get summaries like this every morning.
Free AI-powered recaps of POLITICO's Pulse Check and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.